• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NSB

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD - Corporate Spotlight

9.09% ! 18.0¢
Market Cap $59.86M  !
Healthcare Biotechnology
Add to My Watchlist

NeuroScientific Biopharmaceuticals Limited is an Australia-based company, which is... NeuroScientific Biopharmaceuticals Limited is an Australia-based company, which is engaged in developing peptide-based pharmaceutical drugs that target a number of neurodegenerative conditions with high unmet medical demand. The Company's product portfolio includes EmtinB, a therapeutic peptide initially targeting glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn and EmtinBn). EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body's innate immune response to cell injury. Its StemSmart is a global patented technology engaged in manufacturing cell products. The use of its proprietary StemSmart technology in a special access program for fistulising Crohn’s disease.More

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
18.0¢ 		Change
0.015(9.09%) 		Mkt cap ! $59.86M
Open High Low Value Volume
17.5¢ 18.0¢ 17.0¢ $89.52K 510.3K

Buyers (Bids)

No. Vol. Price($)
1 50000 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 69933 3
View Market Depth
Last trade - 16.10pm 17/09/2025 (20 minute delay) ?
NSB (ASX) Chart

Top Stories

Market Close: The US Fed rate is one thing – but are FDI outflows bringing down a boring ASX in favour of Wall Street?

Good Afternoon and welcome to Market Close for Wednesday 17 September, I’m Jon Davidson. The market’s nervous, that much is clear, putting the ASX in line with Asian peers. We get the Fed rate cut decision on Friday Australia time, and it looked like profit takers ...
Painchek sees modest gain on reports aged care monitoring app bodes well in Scottish pilot Painchek has seen support for its value prop on the back of a Scottish trial that used its 'Adult App' in the "Scottish care system."
Listen: HotCopper Wire Podcast 025 – Locksley rap video gives Hilltop Hoods run for money Welcome to this week’s HotCopperWire, our market watch podcast! Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through the week’s biggest news headlines @ and what they mean for Oz investors.In this Week 38 epis...
ASX Market Open: Fed cuts – and now markets not sure what to do next | Sep 18 The Federal Reserve made the call to cut interest rates in the U.S. quite early this morning, leaving the ASX heading into a red day.
SILEX eyeing one-year breakeven as latest uranium uptick supports updates on enrichment testing SILEX Systems has jumped +13% on Wednesday as wider global uranium stocks on the whole continue to enjoy a risk-on week.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.